记者今天获悉，国家药监局发布《互联网药品医疗器械信息服务备案管理规定》，该《规定》自发布之 日起施行。 《规定》明确了互联网药品医疗器械信息服务备案的内容、办理条件、工作程序、所需资料等相关事 项。《规定》的出台将进一步规范互联网药品医疗器械信息服务备案管理，有效指导各地规范开展备案 工作。 这个《规定》是国家药监局贯彻落实国务院深化"证照分离"改革精神的重要举措。 国家药监局强调，开展互联网药品医疗器械信息服务，应当按照《规定》的要求向所在地省级药品监督 管理部门办理备案。 ...

Group 1 - Since the beginning of the 14th Five-Year Plan, the number of new enterprises in China has increased by 19.999 million, and the number of individual businesses has increased by 33.946 million [2] - The enterprise credit index in China has risen from 128.6 in 2020 to 161.61 in the first half of 2025 [2] - The implementation of the "certificate separation" reform has established a unified market access negative list, facilitating a streamlined process for business registration [2] Group 2 - The introduction of the "Fair Competition Review Regulations" aims to regulate issues related to "malicious competition" in investment promotion and to impose strict institutional constraints [3] - The National Market Supervision Administration has intensified efforts to curb irrational competition, discovering and abolishing 4,218 policies that hinder the flow of resources [3] - The manufacturing quality competitiveness index has improved to 85.86, while the satisfaction rates for service quality have reached 81.33 and 81.62 respectively [3] Group 3 - The National Market Supervision Administration has strengthened food safety regulation, handling 2.2604 million food safety cases [4] - The drug and medical device regulatory reforms have led to a stable drug inspection pass rate of over 99.4% [4] - Six high-risk products are now under production license management, and 15 products are under mandatory product certification management [4]